Specialist VC led the €1.75M investment round into medical technology company Nanordica Medical

Ellex in Estonia advised venture capital firm Specialist VC as the lead investor on the €1.75M seed round to Estonian MedTech company Nanordica Medical.

Superangel and Amalfi also participated in the investment round, which enables Nanordica to develop and bring to market innovative wound care products based on nanotechnology.

“We were inspired by the extraordinary determination and resilience of Nanordica Medical’s founder team. The company’s innovative wound care solution has the potential to positively impact the lives of chronic wound patients across the world”, says Gerri Kodres, the Founder Partner of Specialist VC.

Nanordica Medical, founded in 2019, is a spin-off of the National Institute of Chemical Physics and Biophysics in Estonia Nanordica, which invented and patented innovative antibacterial nanotechnology.

Specialist VC was advised by Ellex Partner Antti Perli, Counsel Rutt Värk, Senior Associates Merlin Liis-Toomela and Hanna Pahk, Tax Counsel Dmitri Rozenblat, and Lawyer Hegle Pärna.